Top Tweets for #AnnaBichikHomeLab

reminder Scientists think they've found a smarter way to heal the human body, not with one regenerative therapy, but by combining several that amplify each other. In a new review, researchers propose that Polydeoxyribonucleotide (PDRN), a regenerative molecule made from purified salmon DNA fragments, could become the centerpiece of next-generation tissue repair when paired with biochemical and physical therapies. PDRN works in 2 powerful ways. It activates the Adenosine A2A receptor (A2AR) to reduce harmful inflammation while stimulating new blood vessel growth, and it supplies DNA building blocks that damaged cells can recycle through the salvage pathway, helping them repair themselves more efficiently. But here's what really caught my attention 👀 The paper argues that regeneration isn't driven by a single "miracle molecule." Instead, the best results come from combining therapies that each target different parts of the healing process. For example: • PDRN + Hyaluronic Acid improves tissue hydration, collagen production, and wound healing. • PDRN + Platelet-Rich Plasma (PRP) enhances the activity of natural growth factors like VEGF, PDGF, and TGF-β. • PDRN + Stem Cells or Exosomes creates a more favorable environment for tissue regeneration and blood vessel formation. • PDRN + Microneedling, Fractional Lasers, or Shockwave Therapy boosts tissue remodeling and accelerates recovery by pairing biological repair with physical stimulation. The review highlights potential applications across chronic wounds, diabetic ulcers, osteoarthritis, tendon injuries, cartilage repair, peripheral nerve damage, muscle regeneration, and even skin rejuvenation. This matters because regenerative medicine has largely focused on finding one perfect treatment. This paper suggests the future may instead be about building multi-target regenerative systems, where different therapies work together like an orchestra instead of acting alone.